Overview
Celiac disease-epilepsy-cerebral calcification syndrome (CEC syndrome), also known as CEC syndrome or the celiac disease-epilepsy-occipital calcification syndrome, is a rare condition characterized by the triad of celiac disease (gluten-sensitive enteropathy), epilepsy, and bilateral cerebral calcifications predominantly located in the occipital and parieto-occipital regions of the brain. The syndrome primarily affects the gastrointestinal system, the central nervous system, and may also involve other organs. Seizures are typically occipital in origin and may manifest as visual disturbances, partial seizures, or generalized tonic-clonic episodes. The cerebral calcifications are typically bilateral and can be detected on CT scan. Patients often present with symptoms of celiac disease including chronic diarrhea, malabsorption, and failure to thrive, alongside neurological manifestations. The exact pathogenesis remains incompletely understood, but it is hypothesized that chronic folate deficiency and immune-mediated mechanisms related to gluten sensitivity may contribute to the cerebral calcifications and epilepsy. Some researchers suggest that prolonged exposure to gluten in genetically susceptible individuals triggers both the intestinal and neurological manifestations. The condition typically presents in childhood or adolescence, though adult-onset cases have been reported. Early diagnosis is important because a strict gluten-free diet may help control seizures and potentially prevent progression of cerebral calcifications, particularly when initiated early in the disease course. However, in many cases, epilepsy may become refractory to standard antiepileptic medications, especially if the gluten-free diet is not adopted early. Antiepileptic drugs are used to manage seizures, and nutritional supplementation (including folic acid) may be beneficial. The prognosis varies depending on the timing of diagnosis and adherence to dietary management.
Also known as:
Multifactorial
Caused by a mix of several genes and environmental factors
Childhood to adulthood
Can begin any time from childhood through adulthood
FDA & Trial Timeline
3 eventsAzienda USL Reggio Emilia - IRCCS
Assistance Publique - Hôpitaux de Paris
Scripps Translational Science Institute
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
No FDA-approved treatments are currently listed for Celiac disease-epilepsy-cerebral calcification syndrome.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Celiac disease-epilepsy-cerebral calcification syndrome at this time.
New trials open frequently. Follow this disease to get notified.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Celiac disease-epilepsy-cerebral calcification syndrome.
Community
No community posts yet. Be the first to share your experience with Celiac disease-epilepsy-cerebral calcification syndrome.
Start the conversation →Latest news about Celiac disease-epilepsy-cerebral calcification syndrome
Disease timeline:
New recruiting trial: Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/Leukemia
A new clinical trial is recruiting patients for Celiac disease-epilepsy-cerebral calcification syndrome
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Celiac disease-epilepsy-cerebral calcification syndrome
What is Celiac disease-epilepsy-cerebral calcification syndrome?
Celiac disease-epilepsy-cerebral calcification syndrome (CEC syndrome), also known as CEC syndrome or the celiac disease-epilepsy-occipital calcification syndrome, is a rare condition characterized by the triad of celiac disease (gluten-sensitive enteropathy), epilepsy, and bilateral cerebral calcifications predominantly located in the occipital and parieto-occipital regions of the brain. The syndrome primarily affects the gastrointestinal system, the central nervous system, and may also involve other organs. Seizures are typically occipital in origin and may manifest as visual disturbances, p
How is Celiac disease-epilepsy-cerebral calcification syndrome inherited?
Celiac disease-epilepsy-cerebral calcification syndrome follows a multifactorial inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Celiac disease-epilepsy-cerebral calcification syndrome typically begin?
Typical onset of Celiac disease-epilepsy-cerebral calcification syndrome is childhood to adulthood. Age of onset can vary across affected individuals.
Which specialists treat Celiac disease-epilepsy-cerebral calcification syndrome?
1 specialists and care centers treating Celiac disease-epilepsy-cerebral calcification syndrome are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.